UCLA Hematology & Oncology Clinic

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urothelial carcinoma	Active, not recruiting	Phase 3	2026-07-22		NCT05911295
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Uveal Neoplasms, connective tissue neoplasm, cutaneous melanoma, eye disorder, fibrosarcoma, melanocytic neoplasm, melanoma, mucosal melanoma, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neurofibroma, neurofibrosarcoma, neuromuscular disease, ocular cancer, peripheral nervous system disorder, peripheral nervous system neoplasm, primitive neuroectodermal tumor, sarcoma, skin disorder, skin neoplasm, uveal disorder, uveal melanoma	Active, not recruiting	Phase 1 / Phase 2	2025-08-07		NCT03611868

Clinical trials